Based on 5 analysts giving stock ratings to Haleon PLC in the past month.
Buy
0 Strong Buy
3 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
10.914USD+9.14%
HLN Analyst Recommendation Trends
In the current month, HLN has received 3 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. HLN average Analyst price target in the last month is 10.914.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
Strong Buy
0
0
0
0
0
0
0
0
Buy
3
3
3
3
3
4
4
4
Hold
2
2
2
2
2
1
1
0
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
5
5
5
5
5
5
5
4
HLN Analyst Rating for Peer Comparison
Updated: Nov 1, 2026
Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Ratings
Analysts
Biogen Inc
BIIB
10
17
10
1
0
38
Amgen Inc
AMGN
4
9
19
3
1
36
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
19
3
1
0
33
Alnylam Pharmaceuticals Inc
ALNY
5
18
9
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Merck & Co Inc
MRK
7
15
9
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Gilead Sciences Inc
GILD
7
18
5
0
0
30
FAQs
What is Haleon PLC's price target?
Analysts forecast that Haleon PLC's price target is USD 10.57, with the highest forecast at USD 13.77 and the lowest forecast at USD 4.90.
What is the analyst rating for Haleon PLC?
Based on the ratings of Haleon PLC's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.